Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Arcutis Biotherapeutics Inc (NASDAQ: ARQT) closed the day trading at $13.08 up 3.15% from the previous closing price of $12.68. In other words, the price has increased by $3.15 from its previous closing price. On the day, 1.46 million shares were traded. ARQT stock price reached its highest trading level at $13.37 during the session, while it also had its lowest trading level at $12.8.
Ratios:
For a better understanding of ARQT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.38 and its Current Ratio is at 2.46. In the meantime, Its Debt-to-Equity ratio is 1.33 whereas as Long-Term Debt/Eq ratio is at 0.69.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 30, 2024, initiated with a Buy rating and assigned the stock a target price of $19.
On August 28, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $15.
Mizuho Upgraded its Neutral to Buy on January 03, 2024, whereas the target price for the stock was revised from $4 to $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 02 ’25 when Welgus Howard G. sold 10,000 shares for $14.67 per share. The transaction valued at 146,714 led to the insider holds 151,944 shares of the business.
Welgus Howard G. bought 10,000 shares of ARQT for $146,714 on Jan 02 ’25. On Dec 31 ’24, another insider, Burnett Patrick, who serves as the insider of the company, sold 1,691 shares for $14.00 each. As a result, the insider received 23,674 and left with 126,978 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARQT now has a Market Capitalization of 1530948608 and an Enterprise Value of 1408560256. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.04 while its Price-to-Book (P/B) ratio in mrq is 9.77. Its current Enterprise Value per Revenue stands at 10.155 whereas that against EBITDA is -7.851.
Stock Price History:
Over the past 52 weeks, ARQT has reached a high of $16.20, while it has fallen to a 52-week low of $3.11. The 50-Day Moving Average of the stock is 3.56%, while the 200-Day Moving Average is calculated to be 28.06%.
Shares Statistics:
Over the past 3-months, ARQT traded about 2.15M shares per day on average, while over the past 10 days, ARQT traded about 1930140 shares per day. A total of 117.00M shares are outstanding, with a floating share count of 102.98M. Insiders hold about 12.02% of the company’s shares, while institutions hold 103.01% stake in the company. Shares short for ARQT as of 1735603200 were 20967062 with a Short Ratio of 9.77, compared to 1732838400 on 23527848. Therefore, it implies a Short% of Shares Outstanding of 20967062 and a Short% of Float of 22.16.
